Alumni Network
nifty 22,402.40
34.40 (0.15%)
24-Apr-2024 | EOD
sensex 73,852.94
114.49 (0.16%)
24-Apr-2024 | EOD
MOFSL 2,353.00
41.95 (1.82%)
24-Apr-2024 | EOD
Industry Update Back
Healthcare : IPM growth restricted by price decline
13-Oct-2017

  • Indian pharmaceutical market's  (IPM) secondary sales growth came in muted in September, primarily due to lower prices   and flat volume growth. IPM growth stood at 2.8% YoY in September and 1% in July-September.
  • After declining by 0.5% in June-  August 2017, prices in the industry witnessed further 1.8% erosion in July-  September. Growth in new products too came down to 2.8% from a high of 3.9% in 1Q and 2QFY17, while volumes   growth was flat. We expect industry growth to remain muted in the coming months due to GST-related issues.
  • Moving annual total (MAT) growth for September came down to 6.2%, as against 7.3% in August.

view report Download report open an account trade now
Explore
© 2015 Motilal Oswal. All rights reserved.
Disclaimer